INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

123 studies · page 1 of 6

2020 / Randomized controlled trial

Soursop juice lowered blood pressure and serum uric acid in a prehypertensive population.

In a randomized controlled trial, 143 subjects with essential prehypertension and high-normal serum uric acid (SUA) levels were assigned to receive 2 × 100 g soursop fruit juice daily or no treatment for 3 months. The soursop group showed significantly lower mean systolic blood pressure after adjustment across examinations, and the control group was more likely to have prehypertension, hypertension, and high-normal or high SUA levels at 6 and 12 weeks. In an analysis using 2017 ACC/AHA guidelines, both systolic and diastolic blood pressure were significantly lower in the treatment group than the control group after 12 weeks.

Alatas H, Sja'bani M, Mustofa M, et al. J Hum Hypertens, 2020. PMID 31462727

2020 / Cluster randomized trial

Replacing regular salt with potassium-enriched substitute lowered blood pressure and hypertension incidence

A cluster randomized trial in 2,376 participants in Peru evaluated replacing household salt with a 75% sodium chloride and 25% potassium chloride substitute. The intervention reduced systolic blood pressure by 1.29 mm Hg (95% CI -2.17 to -0.41) and diastolic blood pressure by 0.76 mm Hg (95% CI -1.39 to -0.13). Among participants normotensive at baseline, salt substitution was linked to a 51% lower risk of developing hypertension (95% CI 29% to 66%).

Bernabe-Ortiz A, Sal Y Rosas VG, Ponce-Lucero V, et al. Nat Med, 2020. PMID 32066973

2018 / Randomized controlled pilot trial

Intermittent and continuous energy restriction achieved similar weight loss in obese veterans.

Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.

Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787

2018 / Randomized controlled trial

Calorie restriction improved cardiometabolic risk markers in healthy nonobese adults over two years

In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.

Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490

2018 / Uncontrolled before-and-after intervention study

A 4-week defined plant-based diet reduced blood pressure, serum lipids, and medication usage in an outpatient clinic setting.

Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002

2018 / Supervised controlled feeding randomized crossover trial

Early time-restricted feeding improved insulin sensitivity, blood pressure, and oxidative stress without weight loss in men with prediabetes.

Researchers conducted a supervised controlled feeding trial to determine if intermittent fasting provides benefits independent of weight loss by feeding participants enough food to maintain weight. Men with prediabetes were randomized to early time-restricted feeding (a 6-hour feeding window with dinner before 3 p.m.) or a control schedule (12-hour feeding period) for 5 weeks, followed by crossover to the alternate schedule. Early time-restricted feeding improved insulin sensitivity, β cell responsiveness, blood pressure, oxidative stress, and appetite without weight loss.

Sutton EF, Beyl R, Early KS, et al. Cell Metab, 2018. PMID 29754952

2018 / Randomized controlled trial

Intermittent and continuous calorie restriction produced comparable 1-year weight loss.

In a 1-year randomized trial, 112 adults with abdominal obesity underwent 6 months of active weight loss followed by 6 months of maintenance. Average weight loss was 8.0 kg (SD 6.5) with intermittent restriction and 9.0 kg (SD 7.1) with continuous restriction (p = 0.6), and weight regain was similar (1.1 kg vs 0.4 kg). Both diets improved blood pressure, waist circumference, triglycerides, and HDL cholesterol equally, though the intermittent group reported higher hunger scores (4.7 vs 3.6, p = 0.002).

Sundfør TM, Svendsen M, Tonstad S Nutr Metab Cardiovasc Dis, 2018. PMID 29778565

2018 / Intervention trial with matched historical controls

An 8-hour time-restricted feeding regimen reduced body weight, energy intake, and systolic blood pressure in obese adults compared to historical controls.

Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.

Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594

2017 / Repeated-measures crossover trial

Energy drink consumption increased exercise systolic blood pressure without improving running economy or perceived exertion in recreational runners.

Fifteen recreational runners completed a graded exercise protocol followed by four 15-minute treadmill economy trials at 70% of VO2max, conducted 1 hour after consuming one of three energy drinks or a placebo. Fifteen-minute systolic blood pressure was significantly lower in the placebo trials (156.93 ± 15.50) compared to the three energy drink trials (163.87 ± 13.30, 166.47 ± 13.71, and 165.00 ± 15.23). No significant differences were observed for diastolic blood pressure, heart rate, VO2, or rating of perceived exertion.

Peveler WW, Sanders GJ, Marczinski CA, et al. J Strength Cond Res, 2017. PMID 27386963

2017 / Randomized controlled trial

Yeast beta-glucan reduced waist circumference, blood pressure, and inflammation in overweight adults

A randomized, double-blind trial gave 44 overweight or obese adults either yeast beta-glucan (up to 954 mg daily) or placebo for six weeks. Compared to placebo, beta-glucan significantly reduced waist circumference (p = 0.037), blood pressure (p = 0.006), and IL-6 at week six (p = 0.005), while increasing IL-10 (p < 0.001). No significant differences appeared in lipid profiles, liver and kidney markers, or nutrient intake.

Mosikanon K, Arthan D, Kettawan A, et al. J Diet Suppl, 2017. PMID 27715351

2017 / Randomized controlled crossover trial

A fasting-mimicking diet reduced body fat, blood pressure, and disease risk factors.

In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.

Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779

2017 / Randomized crossover trial

Circadian misalignment in chronic shift workers significantly increased 24-hour hs-CRP and blood pressure levels.

Chronic shift workers completed two 3-day laboratory protocols simulating night work (12-hour inverted cycles; circadian misalignment) or day work (circadian alignment) in a randomized crossover design. Circadian misalignment increased 24-h hs-CRP by 11% (p < 0.0001) and increased 24-h systolic blood pressure (SBP) by 1.4 mmHg and diastolic blood pressure (DBP) by 0.8 mmHg (both p ≤ 0.038). The increase in 24-h SBP was primarily driven by an increase during wakefulness (+1.7 mmHg; p = 0.017), while the increase in 24-h DBP was mainly during sleep opportunity (+1.8 mmHg; p = 0.005).

Morris CJ, Purvis TE, Mistretta J, et al. J Biol Rhythms, 2017. PMID 28347188

2017 / Randomized crossover trial

Energy drinks prolonged QTc and increased systolic blood pressure more than caffeine alone.

In a randomized crossover trial of 18 healthy adults, participants drank 946 mL of an energy drink or a caffeine-matched control beverage. At 2 hours, the corrected QT interval change was significantly greater following the energy drink compared to caffeine alone (0.44±18.4 ms versus -10.4±14.8 ms; P=0.02). Systolic blood pressure was also higher at 6 hours post-consumption (4.72±4.67 mm Hg versus 0.83±6.09 mm Hg; P=0.01), with no differences observed in diastolic blood pressure or heart rate.

Fletcher EA, Lacey CS, Aaron M, et al. J Am Heart Assoc, 2017. PMID 28446495

2016 / Randomized crossover trial

Concord grape juice improved spatial memory and driving performance in working mothers

In a randomized crossover trial, 25 working mothers aged 40 to 50 years drank 355 mL of Concord grape juice or placebo daily for 12 weeks with a four-week washout. Consumption of the grape juice led to significant improvements in immediate spatial memory compared to placebo. In a subset of 17 participants, grape juice also improved performance during a simulated driving task, with benefits persisting into the subsequent placebo phase.

Lamport DJ, Lawton CL, Merat N, et al. Am J Clin Nutr, 2016. PMID 26864371

2016 / Randomized controlled trial

Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance

A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.

Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322

2016 / Randomized controlled trial

Flaxseed reduced central blood pressure in participants with high baseline blood pressure.

Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.

Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063

2016 / Randomized crossover trial

Tart cherry concentrate lowered systolic blood pressure without improving cognitive performance

In a randomized crossover trial of 27 middle-aged volunteers, participants ingested a 60 ml dose of Montmorency tart cherry concentrate or placebo. Tart cherry intake significantly decreased systolic blood pressure over 3 hours, with peak reductions of 6±2 mmHg at 1 hour compared to placebo. It also altered total and oxygenated hemoglobin levels during cognitive tasks at 1 hour, but cognitive function and mood were not altered.

Keane KM, Haskell-Ramsay CF, Veasey RC, et al. Br J Nutr, 2016. PMID 27989253

2016 / Single-blind, randomized crossover trial

Potassium-enriched salts demonstrated at least 80% public acceptability compared to regular sodium chloride salt in a crossover trial.

A crossover trial evaluated the flavor and taste acceptability of six potassium-enriched (sodium reduced) iodized salts (0%, 5%, 10%, 15%, 20%, 25%, and 30%) compared to regular sodium chloride salt among 100 normal volunteers aged 11 to 64 years. More than 80% of participants either did not distinguish between the two salts even at high potassium levels or preferred the potassium-enriched salt (P < 0.001). Additionally, more participants preferred the flavor of potassium-enriched salt over regular sodium chloride. The authors noted that acceptability requires confirmation in a more general population group.

Maleki A, Soltanian AR, Zeraati F, et al. Clin Hypertens, 2016. PMID 28031983

2015 / Pooled analysis of randomized controlled trials

Six months of soy food or isoflavone intake did not elevate uric acid.

A pooled analysis evaluated two 6-month randomized trials involving 450 postmenopausal women with prehypertension or prediabetes. Compared with milk placebo, participants receiving combined soy foods had a smaller decline in serum uric acid, resulting in a net difference of 14.5 micromol/L (95% CI: 1.93-25.6, p = 0.023) or 4.9% (95% CI: 1.3-8.5%, p = 0.023). Soy foods did not raise absolute urate levels.

Liu ZM, Ho CS, Chen YM, et al. Eur J Nutr, 2015. PMID 24659208

2015 / Randomized controlled trial

Daily blueberry powder reduced blood pressure and arterial stiffness in postmenopausal women.

In an eight-week trial, 48 postmenopausal women with pre- and stage 1-hypertension received 22 g daily of freeze-dried blueberry powder or control powder. Systolic blood pressure (131±17 mm Hg, P<0.05), diastolic blood pressure (75±9 mm Hg, P<0.01), and brachial-ankle pulse wave velocity (1,401±122 cm/second, P<0.01) decreased significantly from baseline in the blueberry group, along with increased nitric oxide levels (15.35±11.16 μmol/L, P<0.01). No changes occurred in the control powder group.

Johnson SA, Figueroa A, Navaei N, et al. J Acad Nutr Diet, 2015. PMID 25578927

2015 / Randomized crossover trial

A high-nitrate vegetable diet increased plasma nitrite and reduced systolic blood pressure.

A randomized crossover trial tested the effects of consuming high-nitrate vegetables versus avoiding them for one week in 19 healthy women. The high-nitrate diet raised plasma nitrate from 24.4 to 61.0 µmol/l and nitrite from 98 to 185 nmol/l (both P < 0.05). Resting systolic blood pressure was reduced from 107 to 103 mmHg after the high-nitrate diet (P < 0.05), whereas the control diet produced no significant changes.

Ashworth A, Mitchell K, Blackwell JR, et al. Public Health Nutr, 2015. PMID 25683748

2015 / Randomized crossover trial

Potassium supplementation attenuated postprandial endothelial dysfunction induced by a high-sodium meal.

In a randomized crossover trial, 39 healthy normotensive adults consumed three test meals with varying sodium and potassium contents on separate occasions. Adding 38 mmol potassium to a 65 mmol sodium meal significantly attenuated the postmeal decrease in flow-mediated dilatation compared with a low-potassium, high-sodium meal (P < 0.05). No significant differences were observed between meals for pulse wave velocity, central augmentation index, or blood pressure.

Blanch N, Clifton PM, Petersen KS, et al. Am J Clin Nutr, 2015. PMID 25787997

2015 / Randomized crossover controlled feeding study

A high-sodium diet reduced brachial artery flow-mediated dilation similarly in both salt-sensitive and salt-resistant adults.

Ten salt-resistant and ten salt-sensitive healthy, normotensive participants completed a controlled feeding study with a run-in diet followed by a 7-day low-sodium diet (20 mmol/day) and a 7-day high-sodium diet (300 mmol/day) in random order. Brachial artery flow-mediated dilation (FMD) was lower during the high-sodium diet compared to the low-sodium diet in both groups (P < 0.001) without differing between groups (FMD: SR LS 10.6 ± 1.3%, SR HS 7.2 ± 1.5%, SS LS 12.5 ± 1.7%, SS HS 7.8 ± 1.4%). Thus, high dietary sodium impaired brachial artery FMD to a similar extent regardless of salt sensitivity.

Matthews EL, Brian MS, Ramick MG, et al. J Appl Physiol (1985), 2015. PMID 26078434

2014 / Randomized crossover trial

A high-potassium meal attenuated the postprandial reduction in flow-mediated dilatation compared with low potassium.

In a randomized crossover study of 32 healthy normotensive volunteers, participants consumed a high-potassium meal (36 mmol) and a low-potassium meal (6 mmol) on separate occasions. Although flow-mediated dilatation dropped after eating in both trials, the reduction was significantly smaller following the high-potassium meal (p < 0.05). Both meals elicited a drop in blood pressure at 30 minutes that resolved by 120 minutes, with no differences observed between diets.

Blanch N, Clifton PM, Keogh JB Nutr Metab Cardiovasc Dis, 2014. PMID 24119989